Thursday

18th Jul 2019

Commission to re-write rules following PIP breast implant scandal

The European Commission has promised to re-write EU legislation on medical devices to avoid a repeat of the breast implant scandal involving now defunct French-firm Poly Implant Prothese (PIP) which emerged last year.

Consumer Protection Commissioner John Dalli told MEPs on Wednesday (13 June) that the issue would be addressed in the upcoming re-draft of the five-year-old Medical Devices directive, which the Commission is expected to publish in September. Although national governments are responsible for public health policy, EU legislation covers over 10,000 medical devices sold in Europe.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 18 year's of archives. 30 days free trial.

... or join as a group

  • Tough rules on medical devices will be proposed in September by the European Commission. (Photo: wikipedia)

Speaking during the Parliament session in Strasbourg, Dalli promised to introduce “a robust proposal that will drastically improve our safety, without overreacting to an incident.” The proposal would include measures to scrutinise all high-risk medical devices before they could be sold, alongside ‘implant cards’ with detailed consumer information to be provided to all patients.

However, despite describing the PIP case as “appalling”, Dalli admitted that the case was “a fraud which could have happened under the most robust authorisation process you could have.”

He added that he had written to national health ministers to demand tight market controls on medical devices in advance of the new legislation.

Last December the French government issued a cancer alert and advised women to remove implants made by PIP.

The implants were banned in 2010 by which time PIP had been illegally selling defective silicone breast implants over several years. By the time the fraud was uncovered an estimated 300,000 women, including 100,000 in Europe, had received the faulty implants, which had been made using industrial silicone normally used in mattresses rather than material approved for medical surgery. Most implants have to be replaced between 10 or 15 years after the initial surgery.

Centre-left MEP Linda McAvan, who co-authored the Parliament’s resolution, called for the cosmetic surgery industry to be tightly regulated and a ban on advertising plastic surgery. She described the PIP case as “a scandal which has highlighted just how casually cosmetic surgery is presented.”

Commissioner Dalli was responding to a resolution initiated by Parliament’s Environment and Public Health committee. The non-binding resolution adopted by MEPs on Thursday (14 June) called for medical devices to be subject to the same pre-authorisation inspection rules as medicines, including unannounced test visits by inspectors. They also called for compulsory breast implant registers in all 27 member states along with a mandatory patient-passport traceability system.

For her part, Monique Goyens, director general of European consumer lobby group BEUC, noted that “health authorities across Europe failed to give consistent information on what to do about defective PIP implants”.

“The PIP fraud is another example for the need of a collective redress system which allows consumers to defend their rights and obtain compensation for the damage they suffered,” she added.

Feature

Medical technology: Advancing too fast for its own good?

The rapid advancement of medical technology has contributed to people living longer, healthier lives but consumer and campaign groups say devices should come under more scrutiny before they are used on patients.

Stakeholder

FIFA's schools programme aims to reach 700m children

Football clubs today invest huge sums of money in youth development and court talented young players from an early age. Children are the future – not only where football is concerned, but also for society in general.

Opinion

A fundamental contradiction in EU drug policy

The knock-on affects from a 'war on drugs' in Europe is creating problems in Albania - and as far afield as Guinea-Bissau, Mali, Bangladesh and the Philippines.

Stakeholders' Highlights

  1. UNESDAUNESDA reduces added sugars 11.9% between 2015-2017
  2. International Partnership for Human RightsEU-Uzbekistan Human Rights Dialogue: EU to raise key fundamental rights issues
  3. Nordic Council of MinistersNo evidence that social media are harmful to young people
  4. Nordic Council of MinistersCanada to host the joint Nordic cultural initiative 2021
  5. Vote for the EU Sutainable Energy AwardsCast your vote for your favourite EUSEW Award finalist. You choose the winner of 2019 Citizen’s Award.
  6. Nordic Council of MinistersEducation gets refugees into work
  7. Counter BalanceSign the petition to help reform the EU’s Bank
  8. UNICEFChild rights organisations encourage candidates for EU elections to become Child Rights Champions
  9. UNESDAUNESDA Outlines 2019-2024 Aspirations: Sustainability, Responsibility, Competitiveness
  10. Counter BalanceRecord citizens’ input to EU bank’s consultation calls on EIB to abandon fossil fuels
  11. International Partnership for Human RightsAnnual EU-Turkmenistan Human Rights Dialogue takes place in Ashgabat
  12. Nordic Council of MinistersNew campaign: spot, capture and share Traces of North

Latest News

  1. Timmermans: von der Leyen will be tough on rule of law
  2. Timmermans trolls 'idiot' Brexit negotiators
  3. Rudderless Europe: Will real Germany please stand up?
  4. PiS & Fidesz claim credit for von der Leyen victory
  5. Von der Leyen faces gender battle for commission posts
  6. EU proposes yearly rule of law 'reports'
  7. Poland 'optimistic' despite new EU law checks
  8. What did we learn from the von der Leyen vote?

Join EUobserver

Support quality EU news

Join us